NEW
Dupixent

Dupixent

dupilumab

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Dupilumab
Indications/Uses
Moderate to severe atopic dermatitis in patients ≥6 yr inadequately controlled w/ topical prescription therapies or when those therapies are not advisable, can be used w/ or w/o topical corticosteroids. Add-on maintenance treatment for severe asthma w/ type 2 inflammation in adults & adolescents ≥12 yr. Maintenance therapy for oral corticosteroid-dependent asthma.
Dosage/Direction for Use
SC Atopic dermatitis Adult, adolescent & ped 6-17 yr, ≥60 kg Initially 600 mg, followed by 300 mg every other wk. Ped 6-17 yr, 30 to <60 kg Initially 400 mg, followed by 200 mg every other wk, 15 to <30 kg Initially 600 mg, followed by 300 mg every 4 wk. Adult & adolescent ≥12 yr Asthma Initially 400 mg, followed by 200 mg every other wk. Severe asthma, patient who are on oral corticosteroids or w/ severe asthma & comorbid moderate to severe atopic dermatitis or severe chronic rhinosinusitis w/ nasal polyposis Initially 600 mg, followed by 300 mg every other wk.
Contraindications
Special Precautions
Discontinue use if hypersensitivity reaction occurs. Not to be inj into tender, damaged, bruised or scarred skin. Not to be used for acute asthma symptoms or exacerbations; acute bronchospasm or status asthmaticus. Conjunctivitis, keratitis; comorbid asthma; parasitic helminth infections; vasculitic rash, worsened pulmonary symptoms, cardiac complications &/or neuropathy presenting in patients w/ eosinophilia. Immunogenicity. Avoid abrupt discontinuation of systemic, topical or inhaled corticosteroids. Pregnancy & lactation. Ped patients <6 yr.
Adverse Reactions
Inj site reactions, conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other HSV infection, dry eye.
Drug Interactions
Avoid use w/ live & non-live vaccines.
MIMS Class
Other Dermatologicals
ATC Classification
D11AH05 - dupilumab ; Belongs to the class of agents for atopic dermatitis, excluding corticosteroids. Used in the treatment of atopic dermatitis.
Presentation/Packing
Form
Dupixent soln for inj 200 mg/1.14 mL
Packing/Price
2 × 1's
Form
Dupixent soln for inj 300 mg/2 mL
Packing/Price
2 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in